Accessibility Menu
PreveCeutical Medical logo

PreveCeutical Medical

(OTC) PRVCF

Current Price$0.01
Market Cap$6.22M
Since IPO (2017)-91%
5 Year-53%
1 Year-57%
1 Month-29%

PreveCeutical Medical Financials at a Glance

Market Cap

$6.22M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$1.63M

EPS (TTM)

-$0.00

P/E Ratio

-4.95

Dividend

$0.00

Beta (Volatility)

0.03 (Low)

Price

$0.01

Volume

20,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

Apr 30, 2026

PRVCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PreveCeutical Medical

Industry

Pharmaceuticals

CEO

Stephen van Deventer

Headquarters

Vancouver, BC V6B 0R6, CA

PRVCF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

59%

Return on Assets

-1%

Earnings Yield

-20.20%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.22M

Shares Outstanding

598.19M

Volume

20.00K

Avg. Volume

16.87K

Financials (TTM)

Gross Profit

-CA$14.41K

Operating Income

-CA$3.36M

EBITDA

-CA$3.35M

Operating Cash Flow

-CA$1.72M

Capital Expenditure

-CA$2.96K

Free Cash Flow

-CA$1.72M

Cash & ST Invst.

CA$10.23K

Total Debt

CA$4.67M

PreveCeutical Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$3.63K

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.22M

N/A

Market Cap/Employee

$888.73K

N/A

Employees

7

N/A

Net Income

CA$1.21M

+601.9%

EBITDA

-CA$717.65K

-356.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$10.23K

-82.7%

Total Debt

CA$4.67M

+4.8%

Accounts Receivable

CA$1.01M

+3607.5%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$4.67M

+6.3%

Return on Assets

-1.12%

N/A

Return on Invested Capital

59.39%

N/A

Free Cash Flow

-CA$533.95K

-701.4%

Operating Cash Flow

-CA$533.95K

-710.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZHCLFZenith Capital Corp.
$0.05+150.00%
PPCBPropanc Biopharma, Inc.
$2.27-6.58%
SRBCFSirona Biochem Corp.
$0.01+0.00%
SYGGFSynairgen plc
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SMCISuper Micro Computer
$30.46-0.05%

Questions About PRVCF

What is the current price of PreveCeutical Medical?

PreveCeutical Medical is trading at $0.01 per share.

What is the 52-week range for PreveCeutical Medical?

Over the past 52 weeks, PreveCeutical Medical has traded between $0.00 and $0.04.

How much debt does PreveCeutical Medical have?

As of the most recent reporting period, PreveCeutical Medical reported total debt of CA$3.41M.

How much cash does PreveCeutical Medical have on hand?

PreveCeutical Medical reported CA$7.47K in cash and cash equivalents in its most recent financial results.

What is PreveCeutical Medical’s dividend yield?

PreveCeutical Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.